Acute Kidney Injury
Market opportunity for Acute Kidney Injury (AKI)
- AKI has become a nosocomial disease with an incidence of 5-7% in hospitalized patients
- Surgery (especially post cardiac surgery)
- Contrast-studies
- 5-24-billion-dollar annual cost
- Mortality of 45-70%
- AKI is increasingly recognized in COVID-19 patients
ACE2 variant protects against AKI in the mouse model of ischemia reperfusion
- This preliminary work was presented at the meeting of the American Society of Nephrology in November of 2019